Metraipolis › archive › dc_2ed8995617bc

Real-world experience with rituximab for multiple sclerosis treatment in a Brazilian tertiary center — Europe PMC PMID:42150598

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42150598
DOI: 10.1055/s-[numero omesso]
License (as archived): solo-consultazione
Archived: 2026-11-03T13:17:30.085Z
SHA-256 of the archived text: 129b9bfe88ba129419dcbecd0cffe0680ee0caa88d32a8d978b668c59cff1202
Stable URL of this page: https://metraipolis.com/documento/dc_2ed8995617bc

How to cite

Real-world experience with rituximab for multiple sclerosis treatment in a Brazilian tertiary center — Europe PMC PMID:42150598 — Europe PMC (en), https://europepmc.org/article/MED/42150598 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2ed8995617bc (Metraipolis archive dc_2ed8995617bc, sha256 129b9bfe88ba129419dcbecd0cffe0680ee0caa88d32a8d978b668c59cff1202)

BibTeX

@misc{dc2ed8995617bc,
  title = {Real-world experience with rituximab for multiple sclerosis treatment in a Brazilian tertiary center — Europe PMC PMID:42150598},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42150598},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2ed8995617bc; sha256 129b9bfe88ba129419dcbecd0cffe0680ee0caa88d32a8d978b668c59cff1202},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42150598. Agents can read the archived copy with the MCP tool read_document.